HCA Healthcare (NYSE:HCA) Stock Crosses Above Two Hundred Day Moving Average - Here's Why

Key Points

• HCA Healthcare shares moved above their 200-day moving average of $422.25, trading as high as $434.46, while the stock holds a consensus “Moderate Buy” rating and an average analyst price target of $463.70.
• The company reported strong recent operating results, with quarterly revenue up 8.7% year over year to $20.23 billion and earnings of $7.59 per share, exceeding estimates. HCA also maintains a quarterly dividend of $0.78 per share.
• Growth initiatives include a South Carolina breast-health joint venture and expansion of an AI-powered nurse handoff tool, although investors face risks from a Pomerantz investigation and an ongoing HCA-Cigna contract dispute in Houston.

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report)'s share price crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $422.25 and traded as high as $434.46. HCA Healthcare shares last traded at $423.3140, with a volume of 1,098,930 shares traded.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: BMO reiterated a $495 price target, well above the reported $439 trading level, signaling continued analyst upside expectations for HCA. BMO price target article
• Positive Sentiment: HCA and Solis Mammography announced a joint venture to expand breast-health and mammography services in South Carolina, potentially supporting service growth and local market share. Solis Mammography partnership article
• Positive Sentiment: HCA is expanding its AI-powered nurse handoff tool to 15 additional hospitals. Wider deployment could improve workflow efficiency and help contain labor-related costs, although the financial impact is not yet quantified. AI nurse handoff tool article
• Neutral Sentiment: HCA brought back former executive Ben Brown to lead StoneSprings Hospital and appointed a CEO at an HCA hospital in Denver. The moves may support operations but are unlikely to materially affect near-term valuation. StoneSprings leadership article
• Neutral Sentiment: HCA scheduled its third-quarter 2026 earnings call for October 27, giving investors a near-term catalyst for updates on admissions, revenue, margins and guidance. HCA earnings call announcement
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of HCA investors. The announcement does not establish wrongdoing, but it adds litigation-related uncertainty and can pressure the shares. Pomerantz investigation article
• Negative Sentiment: HCA Houston and Cigna remain in a contract dispute ahead of an agreement expiration. A breakdown could affect reimbursement rates, patient access and hospital volumes in the market. HCA-Cigna contract dispute article

Analyst Ratings Changes

Several equities research analysts recently commented on HCA shares. Raymond James Financial set a $528.00 target price on HCA Healthcare in a research note on Tuesday, July 7th. BMO Capital Markets assumed coverage on HCA Healthcare in a report on Tuesday, September 22nd. They set an "outperform" rating and a $495.00 price target on the stock. UBS Group dropped their target price on shares of HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Weiss Ratings restated a "hold (c+)" rating on shares of HCA Healthcare in a report on Friday, September 4th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating on the stock in a report on Thursday, August 20th. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $463.70.

HCA Healthcare Trading Down 0.8%

The firm's 50-day moving average is $416.24 and its 200-day moving average is $422.25. The firm has a market cap of $91.65 billion, a price-to-earnings ratio of 14.17, a P/E/G ratio of 1.44 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period last year, the firm earned $6.84 earnings per share. The business's quarterly revenue was up 8.7% compared to the same quarter last year. Analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 16th. HCA Healthcare's payout ratio is currently 10.45%.

Institutional Investors Weigh In On HCA Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Sunbelt Securities Inc. grew its stake in shares of HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company's stock worth $2,954,000 after acquiring an additional 3,945 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in shares of HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company's stock valued at $1,078,966,000 after buying an additional 245,887 shares in the last quarter. Sei Investments Co. raised its holdings in HCA Healthcare by 27.5% during the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company's stock valued at $221,380,000 after acquiring an additional 100,764 shares during the period. Oddo BHF Asset Management Sas boosted its holdings in shares of HCA Healthcare by 40.8% in the fourth quarter. Oddo BHF Asset Management Sas now owns 9,760 shares of the company's stock worth $4,557,000 after acquiring an additional 2,829 shares during the period. Finally, SEB Asset Management AB bought a new stake in shares of HCA Healthcare during the 1st quarter valued at $75,534,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women's and children's care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.